AMENDED AND RESTATED SUBLICENSE AGREEMENTSublicense Agreement • December 27th, 2021 • Moleculin Biotech, Inc. • Pharmaceutical preparations • Texas
This AMENDED AND RESTATED SUBLICENSE AGREEMENT (the “Agreement”) as originally entered into February 19, 2019 (the “Effective Date”) and amended on August 2, 2019, and as further amended on March 22, 2021, (the “2nd Amendment Date”), is entered into as of December 20, 2021, by and between Moleculin Biotech Inc., (“MBI”) having a business address of 5300 Memorial Drive, Suite 950 Houston, TX 77007 and WPD Pharmaceuticals, (“WPD”), a Polish corporation, having a business address of ul. Żwirki i Wigury 101, 02-089 Warszawa. MBI and WPD are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
